The risk of dying over the next decade for STEMI patients who survive the first 90 days after primary PCI is just a few percentage points higher than people in the general population, an observational ...

For patients with STEMI secondary to spontaneous coronary artery dissection (SCAD), primary PCI can produce mortality and 30-day readmission rates similar to what’s seen in those treated for ...

CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with ...

Please provide your email address to receive an email when new articles are posted on . Addressing nonculprit lesions during primary PCI for STEMI was noninferior vs. a staged strategy. The trial was ...

LONDON — There appears to be no advantage for continuing anticoagulation treatment after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), according to ...

When timely angioplasty is unavailable to older ST-segment elevation myocardial infarction (STEMI) patients, a modified pharmaco-invasive reperfusion strategy could be reasonable, according to the ...

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking ...

London, UK - The UK National Institute for Health and Clinical Excellence (NICE) has recommended the use of the anticoagulant bivalirudin (Angiox, the Medicines Company), in combination with aspirin ...

Amsterdam, Netherlands – 28 Aug 2023: Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Stone said during a presentation that past trials of ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Coronary no-reflow phenomenon (NRP), a common adverse complication in patients with ST-segment elevation ...